Tsuneo Konta

TL;DR: The prevalence of CKD stages 1, 2, 3, and 4 + 5 were 0.6, 1.7, 10.7 and 0.2% in the study population, which resulted in predictions of 0.3% of the Japanese adult population—approximately 13.3 million people—were predicted to have CKD in 2005.

TL;DR: Change in albuminuria was consistently associated with subsequent risk of end-stage kidney disease across a range of cohorts, lending support to the use of change inalbuminuria as a surrogate endpoint for end-Stage kidney disease in clinical trials of progression of chronic kidneys disease in the setting of increased album inuria.

TL;DR: Trace proteinuria could be a useful indicator of microalbuminuria in the general population, and especially in subjects at high risk of cardiovascular disease.

TL;DR: UrineACR is the preferred measure of albuminuria; however, if ACR is not available, predicted ACR from PCR or urine dipstick protein may help in CKD screening, staging, and prognosis.

TL;DR: Nephrotic syndrome is a clinical syndrome showing specific features of heavy proteinuria and hypoalbuminemia or hypoproteinemia as its consequence, frequently accompanied by edema, dyslipidemia, abnormalities in coagulation/fibrinolysis, reduced renal function, and immunological disorders.